UTILIZATION OF STEM CELL THERAPY AS A NEW APPROACH TO OVERCOME REPRODUCTIVE DISEASES IN WOMEN

UTILIZATION OF STEM CELL THERAPY AS A NEW APPROACH TO OVERCOME REPRODUCTIVE DISEASES IN WOMEN Downloads The human body contains approximately 37.2 trillion cells, each specialized to perform specific functions within tissues and organs. Stem cells, particularly mesenchymal stem cells (MSCs), have emerged as a promising therapeutic option for various medical conditions due to their regenerative and differentiation capabilities. Female infertility, which significantly impacts quality of life, often results from reproductive disorders such as premature ovarian failure (POF), polycystic ovary syndrome (PCOS), endometriosis, Asherman syndrome, and preeclampsia. Conventional treatments like hormone therapy are limited by long-term risks, including heart disease and cancer, while assisted reproductive technologies are hindered by ethical, safety, and financial concerns. This review explores MSC-based therapies as innovative alternatives for addressing female reproductive disorders. MSCs demonstrate potential in regenerating ovarian cells, restoring hormonal balance, and repairing uterine tissue. For POF, MSC therapy replenishes ovarian cells, improves hormone levels, and restores function. In PCOS, MSCs reduce inflammation and fibrosis while enhancing ovarian function. Endometriosis management benefits from MSCs' ability to repair endometrial damage and improve uterine receptivity. MSCs also show efficacy in reducing fibrosis and increasing vascularization in Asherman syndrome and repairing placental damage in preeclampsia by mitigating oxidative stress and inflammation. This review synthesizes findings from recent studies to highlight MSCs' role in advancing gynecological medicine, presenting them as a safe, effective, and sustainable therapeutic approach for treating infertility and enhancing reproductive health. Artemova, D., Vishnyakova, P., Gantsova, E., Elchaninov, A., Fatkhudinov, T. and Sukhikh, G. (2023), “The prospects of cell therapy for endometriosis”, Journal of Assisted Reproduction and Genetics, Vol. 40 No. 5, pp. 955-67. Asherman, J. G. (1948), “Amenorrhoea Traumatica (Atretica)”, Journal of Obstetrics and Gynaecology, Vol. 55 No. 1, pp. 23-30. Benor, A., Gay, S. and DeCherney, A. (2020), “An update on stem cell therapy for Asherman syndrome”, Journal of Assisted Reproduction and Genetics, Vol. 37 No. 7, pp. 1511-29. Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F., Vitale, L., Pelleri, M. C., Tassani, S., Piva, F., Perez-Amodio, S., Strippoli, P. and Canaider, S. (2013), “An estimation of the number of cells in the human body”, Annals of Human Biology,Vol. 40 No. 6, pp. 463-71. Cen, J., Zhang, Y., Bai, Y., Ma, S., Zhang, C., Jin, L., Duan, S., Du, Y. and Guo, Y. (2022), “Research progress of stem cell therapy for endometrial injury”, Materials Today Bio, Vol. 16. Chaiworapongsa, T., Chaemsaithong, P., Yeo, L. and Romero, R. (2014), “Pre-eclampsia part 1: current understanding of its pathophysiology”, Nature Reviews Nephrology, Vol. 10 No. 8, pp. 466-80. Dahiphale, S. M., Potdar, J., Acharya, N., Jyotsna, G., Saloni, and Desale, R. (2024), “Congenital Anomalies of the Female Genital Tract: A Comprehensive Review”, 16 No. 3, pp. e56753. Dai, F., Wang, R., Deng, Z., Yang, D., Wang, L., Wu, M., Hu, W. and Cheng, Y. (2023), “Comparison of the diferent animal modeling and therapy methods of premature ovarian failure in animal model”, Stem Cell Research and Therapy, Vol. 14 No. 1, pp. 135. Ding, D., Shyu, W. and Lin, S. (2011), “Mesenchymal Stem Cells”, Cell Transplantation, Vol. 20 No. 1, pp. 5-14. Esfandyari, S., Chugh, R. M., Park, H., Hobeika, E., Ulin, M. and Al-Hendy, A. (2020), “Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility”, Cells, Vol. 9 No. 10, pp. 2253. Fu, Y., Ji, J., Shan, F., Li, J. and Rong, H. (2021), “Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities”, Stem Cell Research and Therapy, Vol. 12 No. 1, pp. 161. Galipeau, J. and Sensébé, L. (2018), “Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities”, Cell Stem Cell, Vol. 22 No. 6, pp. 824-33. Gurung, S., Williams, S., Deane, J. A., Werkmeister, J. A. and Gargett, C. E. (2018), “The Transcriptome of Human Endometrial Mesenchymal Stem Cells Under TGFβR Inhibition Reveals Improved Potential for Cell-Based Therapies”, Frontiers in Cell and Developmental Biology, Vol. 6, pp. 164. Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., Heke, M. and Nguyen, L. T. (2022), “Stem cell-based therapy for human diseases”, Signal Transduction and Targeted Therapy, Vol. 7 No. 1, pp. 272. Ivkošic, I. E., Fureš, R., Ćosić, V., Mikelin, N., Bulić, L., Dobranić, D., Brlek, P. and Primorac, D. (2023), “Unlocking the Potential of Mesenchymal Stem Cells in Gynecology: Where Are We Now?”, Journal of Personalized Medicine, Vol. 13 No. 8, pp. 1253. Jin, S., Wu, C., Chen, M., Sun, D. and Zhang, H. (2022), “The pathological and therapeutic roles of mesenchymal stem cells in preeclampsia”, Frontiers in Medicine, Vol. 9. Liao, Z., Liu, C., Wang, L., Sui, C. and Zhang, H. (2021), “Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases”, Frontiers in Endocrinology, Vol. 12. Liu, X., Li, J., Wang, W., Ren, X. and Hu, J. (2023), “Therapeutic restoration of female reproductive and endocrine dysfunction using stem cells”, Life Sciences, Vol. 322. Mutlu, L., Hufnagel, D. and Taylor, H. S. (2015), “The Endometrium as a Source of Mesenchymal Stem Cells for Regenerative Medicine”, Biology of Reproduction, Vol. 92 No. 6, pp. 1-11. Naji, A., Rouas-Freiss, N., Durrbach, A., Carosella, E. D., Sensébé, L. and Deschaseaux, F. (2013), “Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy”, Stem Cells, Vol. 31 No. 11, pp. 2296-303. Prayitno, G. D., Lestari, K., Sartika, C. R., Djuwantono, T., Widjaya, A., Muharam, R., Hidayat, Y. M., Wulandari, D., Haifa, R., Naura, N. F., Marbun, K. T. and Zahrah, A. (2022), “Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review”, Medicines, Vol. 10, No. 1. Shareghi-Oskoue, O., Aghebati-Maleki, L. and Yousefi, M. (2021), “Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure”, Stem Cell Research and Therapy, Vol. 12 No. 1, pp. 454. Squillaro, T., Peluso, G. and Galderisi, U. (2016), “Clinical Trials With Mesenchymal Stem Cells: An Update”, Cell Transplantation, Vol. 25 No. 5, pp. 829-48. Taylor, H., Pal, L., and Seli, E. (2019), “Speroff’s Clinical Gynecologic Endocrinology and Infertility, 9th ed”, Lippincott Williams & Wilkins: Philadelphia, PA, USA. Ullah, I., Subbarao, R. B. and Rho, G. J. (2015), “Human mesenchymal stem cells - current trends and future prospective”, Bioscience Reports, Vol. 35 No. 2, pp. e00191. Yang, J. and Huang, F. (2014), “Stem cell and endometriosis: new knowledge may be producing novel therapies”, International Journal of Clinical and Experimental Medicine, Vol. 7 No. 11, pp. 3853-8. Zhang, S., Mao, Y., Zhao, X., Zhang, H., Ma, M., Long, X. and Wang, S. (2021), “Intrauterine Adhesions (IUAs) or Asherman’s Syndrome (AS) and the Stem Cells Treatment: A Systemic Review and Meta-Analysis”, Journal of Biosciences and Medicines, Vol. 9 No. 1, pp. 105-18. Zhang, Y., Shi, L., Lin, X., Zhou, F., Xin, L., Xu, W., Yu, H., Li, J., Pan, M., Pan, Y., Dai, Y., Zhang, Y., Shen, J., Zhao, L., Lu, M. and Zhang, S. (2021), “Unresponsive thin endometrium caused by Asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: a pilot study”, Stem Cell Research and Therapy, Vol. 12. Zhao, Y., Chen, S., Su, P., Huang, F., Shi, Y., Shi, Q. and Lin, S. (2019), “Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female derived exosomes inhibit ovarian granulosa cells inflammatory response through inhibition of NF-κB signaling in polycystic ovary syndrome”, Journal of Reproductive Immunology, Vol. 152. Zhao, Y., Pan, S. and Wu, X. (2022), “Human umbilical cord mesenchymal stem cell- Reproductive Diseases”, Stem Cells International, Vol. 2019. Copyright (c) 2024 Rizki Zeillatul Warda, Sumadi This work is licensed under a Creative Commons Attribution 4.0 International License. 1. The journal allows the author to hold the copyright of the article without restrictions. 2. The journal allows the author(s) to retain publishing rights without ristrictions. 3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution (CC BY).